Blue Bay Capital Fund

Blue Bay Capital, also known as Qingwan Capital, is a venture capital firm headquartered in Shenzhen, China, with a specialized focus on the life sciences and healthcare sectors. The firm primarily invests in early-to-growth stage companies that are developing innovative biopharmaceuticals, advanced medical devices, and in vitro diagnostic (IVD) solutions. Blue Bay Capital provides its portfolio companies with not only financial investment but also strategic industrial resources and guidance to facilitate their growth in the competitive Chinese and global markets. The firm is recognized for its deep industry expertise and its role in supporting startups that address significant unmet medical needs through cutting-edge technology. Since its inception in 2016, Blue Bay Capital has become an active player in the healthcare investment landscape, bridging the gap between scientific research and commercial success.